# Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with <scp>EGFR G719X</scp>/<scp>L861Q</scp>/<scp>S768I</scp>

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-potential-resistance-mechanisms-of-afatinib-in-advanced-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lanlan Pang,Jiadi Gan,Jiaming Tan,Yihua Huang,Jun Liao,Wei‐Ting Liang,Pengbo Deng,Wen‐Feng Fang |
| Citations | 24 |
| DOI | 10.1002/cncr.34451 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4297613945 |
| PMID | 36069292 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Lanlan Pang](https://scholariq.org/researchers/lanlan-pang/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.